Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

Opinion: Premature regulatory approval by the FDA

Mosunetuzumab monotherapy demonstrates durable efficacy with a manageable safety profile in R/R follicular lymphoma

Addition of platinum to standard neoadjuvant chemotherapy improves EFS in patients with TNMBC

Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma

Treatment decision guided by CTC count may improve long-term outcomes for mBC

The future of precision oncology

The concept of pan-tumour therapeutics

Access to Oncology Medicines Coalition - The Medicines Patent Pool

Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal breast carcinoma

Cloud software for helping build quality assurance in radiotherapy

Is Latin America ready to overcome the challenges of implementing Precision Medicine?